Yixiao Wang Selected Research

Yixiao Wang Research Topics

Disease

9	Neoplasms (Cancer) 05/2024 - 10/2011
6	Pre-Eclampsia (Preeclampsia) 12/2024 - 01/2021
3	Hypertension (High Blood Pressure) 04/2024 - 02/2022
3	Neoplasm Metastasis (Metastasis) 08/2022 - 10/2021
2	Infections 01/2023 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2021
1	Asphyxia (Suffocation) 04/2024
1	Alzheimer Disease (Alzheimer's Disease) 02/2024
1	Ovarian Neoplasms (Ovarian Cancer) 01/2024
1	Inflammation (Inflammations) 01/2024
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023
1	Postpartum Depression (Post-Natal Depression) 12/2023
1	Color Vision Defects (Color Blindness) 12/2023
1	Blue cone monochromatism 12/2023
1	Squamous Cell Carcinoma of Head and Neck 12/2023
1	Wounds and Injuries (Trauma) 12/2023
1	Pregnancy Complications 11/2023
1	Birth Weight (Birth Weights) 11/2023
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2023
1	Atherosclerosis 06/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Bites and Stings (Sting) 01/2023
1	Blindness (Hysterical Blindness) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Endometriosis 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Diabetic Cardiomyopathies 10/2022
1	Esophageal Neoplasms (Esophageal Cancer) 08/2022
1	Pain (Aches) 01/2022
1	Keloid 01/2022
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2021
1	COVID-19 01/2021
1	Anosmia 01/2021
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2021

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2021
4	LipidsIBA 06/2023 - 10/2016
2	Therapeutic UsesIBA 02/2024 - 01/2022
2	LipopolysaccharidesIBA 01/2024 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 06/2023
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 02/2022
2	UbiquitinIBA 01/2023 - 01/2022
2	IronIBA 01/2023 - 01/2017
2	LigandsIBA 01/2022 - 10/2016
1	Monounsaturated Fatty AcidsIBA 12/2024
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2024
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 05/2024
1	Indicators and Reagents (Reagents)IBA 05/2024
1	Tuberculin (PPD)IBA 12/2023
1	DisulfidesIBA 12/2023
1	Arginine (L-Arginine)FDA Link 12/2023
1	CarbonIBA 12/2023
1	Benzo(a)pyreneIBA 12/2023
1	BilirubinIBA 11/2023
1	Sulfur DioxideIBA 11/2023
1	Alkaline PhosphataseIBA 11/2023
1	Air Pollutants (Pollutants, Air)IBA 11/2023
1	Particulate MatterIBA 11/2023
1	HomocysteineIBA 11/2023
1	Apolipoproteins E (ApoE)IBA 06/2023
1	NucleotidesIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Oral ContraceptivesIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	NLR ProteinsIBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	InterferonsIBA 01/2023
1	2-chloro-5-nitrobenzanilideIBA 10/2022
1	Streptozocin (Streptozotocin)FDA Link 10/2022
1	MicroRNAs (MicroRNA)IBA 02/2022
1	SteroidsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	CollagenIBA 01/2022
1	perillaldehydeIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	swerosideIBA 10/2021
1	CateninsIBA 10/2021
1	SugarsIBA 02/2021
1	ABO Blood-Group SystemIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Zinc Sulfate FDA Link 01/2021

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2024 - 08/2022
1	Cesarean Section (Caesarean Section) 04/2024
1	Length of Stay 04/2024
1	Electroacupuncture 02/2024
1	Immunotherapy 01/2024
1	Thyroidectomy 12/2023
1	Neoadjuvant Therapy 08/2022
1	Cryosurgery 01/2022
1	Injections 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Radiotherapy 01/2022
1	Aftercare (After-Treatment) 01/2022